NAA15 抗体 (Middle Region)
Quick Overview for NAA15 抗体 (Middle Region) (ABIN633171)
抗原
See all NAA15 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- Middle Region
-
特异性
- NARG1 antibody was raised against the middle region of NARG1
-
纯化方法
- Affinity purified
-
免疫原
- NARG1 antibody was raised using the middle region of NARG1 corresponding to a region with amino acids PPVFNTLRSLYKDKEKVAIIEELVVGYETSLKSCRLFNPNDDGKEEPPTT
-
-
-
-
应用备注
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
说明
-
NARG1 Blocking Peptide, (ABIN5614917), is also available for use as a blocking control in assays to test for specificity of this NARG1 antibody
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of NARG1 antibody in PBS
-
浓度
- Lot specific
-
缓冲液
- PBS
-
注意事项
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
储存条件
- 4 °C/-20 °C
-
储存方法
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- NAA15 (N(alpha)-Acetyltransferase 15, NatA Auxiliary Subunit (NAA15))
-
别名
- NARG1
-
背景
- The ARD1A-NARG1 complex displays alpha (N-terminal) acetyltransferase activity that may be important for vascular, hematopoietic and neuronal growth and development. NARG1 is required to control retinal neovascularization in adult ocular endothelial cells. In complex with G22P1 and XRCC5 (Ku80), up-regulates transcription from the osteocalcin promoter.
-
分子量
- 101 kDa (MW of target protein)
抗原
-